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Abstract
The TGF-beta member myostatin acts as a
negative regulator of skeletal muscle mass.
The Compact mice were selected for high pro-
tein content and hypermuscularity, and carry a
naturally occurring 12-bp deletion in the
propeptide region of the myostatin precursor.
We aimed to investigate the cellular character-
istics and the glycogen distribution of the
Compact tibialis anterior (TA) muscle by quan-
titative histochemistry and spectrophotometry.
We have found that the deficiency in myostatin
resulted in significantly increased weight of
the investigated hindlimb muscles compared
to wild type. Although the average glycogen
content of the individual fibers kept
unchanged, the total amount of glycogen in the
Compact TA muscle increased two-fold, which
can be explained by the presence of more
fibers in Compact compared to wild type mus-
cle. Moreover, the ratio of the most glycolytic
IIB fibers significantly increased in the
Compact TA muscle, of which glycogen content
was the highest among the fast fibers. In sum-
mary, myostatin deficiency caused elevated
amount of glycogen in the TA muscle but did
not increase the glycogen content of the indi-
vidual fibers despite the marked glycolytic shift
observed in Compact mice.
Introduction 
Myostatin (growth/differentiation factor-8,
GDF-8), a member of the TGF-beta superfami-
ly is a potent negative regulator of skeletal
muscle growth.1 Knocking out of myostatin or
naturally occurring mutations, e.g., in human,
mice, cattle, dog and porcine2-6 lead to large
and widespread increase of the skeletal muscle
mass. Knockout mice show marked hypermus-
cularity due to both hyperplasia (increased
fiber number) and hypertrophy (increased
thickness of the fibers),1 whereas Belgian Blue
double-muscled (DM) cattle contain almost
double number of muscle fibers due to myo-
statin mutation.7,8 Muscle metabolism in DM
cattle or knockout mice shifted into the gly-
colytic toward exhibiting an increased propor-
tion of fast glycolytic white fibers.8-10
The Compact mice arose during a long-term
selection program to reach the maximal pro-
tein accretion and hypermuscularity.11 Genetic
analysis of the Hungarian subpopulation of the
Compact line identified a 12-bp deletion in the
prodomain region of the precursor myostatin;12
therefore, the biologically active growth factor
part is intact. However, additional modifier
genes should be present to determine the full
expressivity of the phenotype.13,14 The precise
biological, biochemical effect of the Compact
mutation is poorly understood; the mutant
propeptide region may play a role in the proper
folding, secretion and targeting of mature
myostatin.12 Hypermuscularity caused by
Compact mutation results from muscle fiber
hyperplasia rather than hypertrophy, and mus-
cle metabolism shifted towards glycolytic
direction.15,16 We hypothesized that not only
the increased protein amount but also the
higher glycogen content may account for the
increased muscle weight of the Compacts;
therefore, in this present study we aimed to
analyze the muscle cellularity of the Compact
mice focusing on the glycogen content and the
fiber-type specific glycogen distribution. Here
we show that the glycogen content of the IIB
fibers was the highest among the fast fibers in
the tibialis anterior (TA) muscle. The myo-
statin deficiency of Compact mice resulted in
elevated glycogen content of the TA muscle but
the average glycogen content of the individual
fibers remained unchanged despite the
marked glycolytic shift.
Materials and MethodsAnimals and sample collection
This investigation conformed to the National
Institutes of Health Guide for the Care and Use
of Laboratory Animals (NIH Pub. No. 85-23,
revised 1996) and was approved by the local
ethics committee at the University of Szeged.
We performed our experiments on 12 week-old
male myostatin mutant Compact (47.3±0.76 g;
n=8) and wild type BALB/c (25.0±0.58 g; n=4)
mice. The origin and the selection procedure of
the Compact mice were described by Baán and
colleagues.16 Briefly, the Compact line was
selected initially in Berlin on the basis of high
protein mass and hypermuscularity. The
Hungarian subpopulation of this Compact line
was inbred and kept for more than 20 years in
the Institute for Animal Biology, Agricultural
Animal Center (Gödöllő, Hungary), while they
have been breeding since 2010 in the
Department of Biochemistry, Faculty of General
Medicine, University of Szeged (Szeged,
Hungary). The non-selected BALB/c mice
exhibiting wild-type myostatin gene were
obtained from the Biological Research Centre of
the Hungarian Academy of Sciences (Szeged,
Hungary). The animals were kept under con-
trolled temperature with 12/12 h light/dark
cycles, and were fed standard chow and tap
water ad libitum. Mice were anaesthetized by
intraperitoneal injection of chloral hydrate (3%
chloral hydrate, 0.15 mL/10 g body weight). The
quadriceps femoris (QF), biceps femoris (BF),
gastrocnemius (Gastro), tibialis anterior (TA)
and extensor digitorum longus (EDL) muscles
were removed and frozen immediately in
isopentane cooled by liquid nitrogen and stored
at -80°C until further processing. The TA mus-
cle from the right hindlimb was used for the
spectrophotometric determination of glycogen
and protein content, whereas morphological
analysis [Periodic Acid Schiff (PAS)-staining,
immunohistochemistry] was performed on the
contralateral TA muscle. 
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Glycogen and protein determina-tion by spectrophotometry
Muscle glycogen was measured as glucose
residues after acidic hydrolysis by a standard
enzymatic assay. Briefly, following cryogenic
milling the samples were digested for 1.5 h in
2.0 M HCl (250 µL HCl/10 mg muscle tissue) at
100°C. After lysis the samples were cooled to
room temperature and neutralized by adding of
equal amount of 2.0 M NaOH. Thereafter, the
samples were centrifuged for 10 min at
21,000× g (Hettich Universal 320R, DJB,
Labcare Ltd., Buckinghamshire, UK) at room
temperature, and the supernatants were
removed. The concentration of glucose was
determined from the supernatant by
Hexokinase kit (Roche, Mannheim, Germany). 
Muscles were homogenized in a buffer (0.1
M Tris-HCl pH 8.0, 0.01 M EDTA, 10% SDS)
containing protease inhibitor cocktail (Sigma-
Aldrich, St. Louis, MO, USA) to extract the total
protein amount. The incubation of the samples
at 99°C for 60 s was followed by centrifugation
at 11,000× g for 5 min (Hettich Universal
320R, DJB, Labcare Ltd.) at room temperature
to remove cellular debris. The supernatant pro-
tein content was determined by BCA Protein
Assay Reagent (Thermo Scientific, Rockford,
IL, USA) in agreement with the manufacturer’s
instructions. 
Spectrophotometry was performed on
Fluostar Optima (BMG Labtech, Ortenberg,
Germany) and data were analyzed on Mars
Data Analysis Software (BMG Labtech).PAS-staining
Glycogen was detected by performing PAS-
staining on 10 µm cryosections of the TA mus-
cle. Sections were fixed for 1 h at 4°C in 3.7%
formaldehyde in ethanol immediately to avoid
glycogen breakdown, and incubated for 15 min
with 0.5% periodic acid (Sigma Aldrich) at
room temperature, followed by 5 s washing in
tap water and deionized water four times.
Then the sections were incubated in Schiff’s
reagent for 1 h at room temperature, followed
by 5 min incubation (twice) in potassium
metabisulfite in deionized water. Thereafter,
gently washing of the slides for 10 s under run-
ning hand-warm tap water was followed by
washing three times for 5 s in deionized water.
Finally, the sections were incubated for 30 s in
50, 70, 90, 100% ethanol and for 15 s in toluol,
then were mounted with Entellan.Immunohistochemistry
Fiber-type analysis was performed on 10 µm
serial cryosections of the midbelly region of TA
muscle. The sections were blocked in 5% non-
fat milk powder (BioRad, Berkeley, CA, USA)
in PBS, and then incubated with mouse mono-
clonal primary antibodies. BA-D5 (1:25), sc-71
(1:25) and BFF3 (1:5) primary antibodies were
used, specific for Myosin Heavy Chain I
(MyHCI, slow oxidative), MyHCIIA (fast oxida-
tive) and MyHCIIB (fast glycolytic).17,18 After
incubation with the peroxidase-conjugated
secondary antibody (rabbit anti-mouse; Dako,
Glostrup, Denmark), the immunocomplexes
were visualized by 3,3’-diaminobenzidine. We
could not detect BA-D5 positive (MyHCI) fibers
in the TA muscle; therefore, the fibers stained
with neither MyHCIIA nor MyHCIIB were con-
sidered as MyHCIIX fibers.Determination of the glycogen con-tent of the individual muscle fibers
Photos were taken with 10x objective using
a Nikon Labophot-2 microscope equipped with
Olympus DP71 camera. The full cross section-
al areas (CSAs) of the muscles were recon-
structed from the microscopic images by
Cell*B software (Olympus DP Soft software,
ver. 3.2, Soft Imaging System GmbH, Munster,
Germany).
The glycogen content of an individual fiber
(OD*mm2) can be predicted by multiplying the
average intensity of PAS-staining by the CSA of
the fiber. Average intensity (optical density,
OD) of PAS-staining (0-1 OD), CSAs of all
fibers (µm2) and fiber numbers were deter-
mined on the whole muscle CSA on greyscale
converted PAS-stained, panoramic images by
Digimizer software (Medcalc software,
Mariakelke, Belgium). 
The fiber-type specific average intensity of
PAS-staining and the CSAs of the different
fiber types were determined on 2-3 representa-
tive microscopic fields of both superficial and
deep regions of the TA muscle (400-1000
fibers/sample, 14-17% of total fiber number
with 10x objective). These muscle regions
were selected for analysis because the tibialis
anterior muscle shows an increasing gradient
of fibres having a high oxidative enzyme activ-
ity proceeding from the superficial to the deep
region of the muscle.19 Both the sc-71
(MyHCIIA) and the BF-F3 (MyHCIIB) stained
regions were matched with the PAS-stained
identical regions on serial sections to analyze
the glycogen content of the different fiber
types. The glycogen-index (%) of a fiber-type
was defined as the average OD * µm2 value of
a fiber type * fiber type proportion / summa-
rized OD * µm2 * fiber type proportion values to
compare the total glycogen content of the dif-
ferent fiber types.  Statistical analysis
Statistical evaluations were performed by
unpaired t-test to assess the effect of Compact
mutation on body weight, absolute and normal-
ized weights of muscles, total protein and
glycogen content of the whole TA muscle deter-
mined by spectrophotometry, relative distribu-
tion of the different fiber types, average inten-
sity of PAS-staining of the fibers on whole
muscle CSA, average area of the fibers, aver-
age glycogen content of the fibers and total
glycogen content of the TA muscle based on
PAS-staining. The applied statistical method
was one-way ANOVA followed by Newman-
Keuls post hoc test (GraphPad Software, Inc.,
San Diego, CA, USA) for the analysis of the
fiber-type specific alterations of average area
of fibers, average intensity of PAS-staining and
average glycogen content of the different fiber
types on the whole CSA or in the superficial
and deep regions of TA muscle; and for the
analysis of glycogen index. All data is
expressed as means ± SEM. 
ResultsBody weight and muscle weights
First, we compared the body weights and the
weights of the investigated hindlimb muscles
of the Compact mice and the wild type BALB/c
line. Here we show that the body weight of the
Compact mice is almost two-fold larger
(P<0.001, Table 1). The absolute weights of
the investigated hindlimb muscles such as
quadriceps femoris, biceps femoris, gastrocne-
mius, tibialis anterior and extensor digitorum
longus were at least two-fold larger in
Compacts (P<0.001; Table 1). The muscle
weights normalized to body weight significant-
ly increased in Compact QF (1.23-fold;
P<0.001), BF (1.3-fold; P<0.001), Gastro (1.34-
fold; P<0.001), TA (1.35-fold; P<0.001) and
EDL (1.3-fold; P<0.01) muscles compared to
BALB/c line (Table 1). Muscle characteristics in Compactmice
The Compact line was selected for high pro-
tein content and hypermuscularity.11 Beside
the increased protein amount the higher glyco-
gen content may account for the increased
muscle weight of the Compact mice. Thus, we
measured both total protein and glycogen
amounts of the fast glycolytic TA muscle by
spectrophotometry. Similarly to the two-fold
increase in total protein content (P<0.001;
Table 1), the amount of glycogen was 1.9-fold
greater (P<0.01; Table 1) in the Compact TA
muscle compared to the wild type. The remark-
able increase in protein content was even
higher than that of glycogen level proving the
significance of protein accretion in the pheno-
type of Compactmice. Next we tested, whether
the higher glycogen amount of the Compact
muscle is caused by the changes in the glyco-
gen content of the individual muscle fibers. To
analyze this, first we determined the OD of
PAS-staining and fiber sizes on the whole CSA
of the TA muscle (Figure 1). The average
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intensity of PAS-staining did not show signifi-
cant change in Compact muscle fibers com-
pared to those of the wild type muscle (Figure
1C), and no significant difference was
observed regarding the average CSAs of the
fibers either (Figure 1D).
The average intensity of PAS-staining multi-
plied by the value of fiber size is suitable to
estimate the average glycogen content of the
individual fibers. Comparing the fibers aver-
age glycogen content we could not detect any
significant changes between the two groups of
animals (Figure 1E). Similar to previously
reported results,15,16  the fiber number
increased 1.7-fold in Compact animals
(P<0.001; Table 2). Multiplying the average
glycogen content of the individual fibers by the
increased fiber number we detected a similar,
two-fold increase in the glycogen content of
the whole muscle by PAS-staining (P<0.05;
Figure 1F) as measured by spectrophotometry
(Table 1).  
Taken together, the average glycogen con-
tent of the individual fibers did not change;
therefore, the increased fiber number can
explain the elevated glycogen amount of the
Compact TA muscle.Fiber-type specific alterations inmuscle cellularity 
To analyze the possible presence of the
fiber-type specific alterations of the glycogen
content, first we examined the fiber type com-
position of TA muscle and measured the CSAs
of the different fiber types on serial sections
immunostained by antibodies against the dif-
ferent isoforms of MyHCs (Figure 2).
Regarding the fiber composition of the
Compact muscle, we could not detect the slow
MyHCI isoform in TA muscles (Table 2) in
accordance with the literature.20 The ratio of
IIB fibers (P<0.01; Table 2) increased 1.6-fold
with concomitant decreases of IIX (P<0.05;
Table 2) and IIA fibers (P<0.001; Table 2) indi-
cating a glycolytic shift. Because the number
of IIA fibers in Compact TA was very low (Table
2), we could not perform statistical analysis on
this type of fibers. Remarkable differences
were observed comparing the sizes of the dif-
ferent fiber types on the whole CSA of the mus-
cle. As in wild type animals, the CSA of type IIB
fibers was 1.44-fold larger than those of type
IIX; and IIX fibers were 1.52-fold larger than
the IIA ones (P<0.01; Figure 3A). In Compact
mice we found a similar result: the CSA of type
IIB fibers was 1.62-fold bigger than those of IIX
fibers (P<0.001; Figure 3A). Comparing the
two mice lines we did not find any differences
between the average size of either IIB or IIX
fibers. The frequency distributions of both the
IIX and IIB fiber sizes showed similar shapes
in Compact and wild type mice (Figure 3 B,C).
The histograms of IIX fibers (Figure 3B)
revealed right-skewed distribution in both
groups of animals. In case of IIB fibers the bell-
shaped curves were wider in Compact and
BALB/c animals (Figure 3C) than those of IIX
fibers (Figure 3B). The superficial and deep
regions of the TA muscle consist of different
fiber types;10,19 therefore, we performed our
measurements on both regions as well.
Original Paper
Table 1. Body weight, absolute and normalized weights of the quadriceps femoris, biceps
femoris, gastrocnemius, tibialis anterior and extensor digitorum longus muscles of 12
week-old, male BALB/c and Compact mice (n= 4-8). Total protein amount and glycogen
content of the TA muscle determined by spectrophotometry in BALB/c and Compact
mice (n=4-6).  
Item BALB/c Compact P value
Bw (g) 25.0±0.58 47.3±0.76 <0.001
Muscle weights
QF (mg) 206±6.33 470±12.19 <0.001
BF (mg) 167±7.23 420±13.83 <0.001
Gastro (mg) 140±3.82 352±7.42 <0.001
TA (mg) 45.3±0.73 114±1.48 <0.001
EDL (mg) 10.0±0.65 23.5±0.35 <0.001
Muscle weights/bw
QF/bw (mg/g) 8.0±0.12 10.0±0.20 <0.001
BF/bw (mg/g) 6.5±0.12 8.5±0.37
Gastro/bw (mg/g) 5.5±0.11 7.4±0.12 <0.001
TA/bw (mg/g) 1.77±0.03 2.40±0.04 <0.001
EDL/bw (mg/g) 0.39±0.02 0.51±0.01 <0.01
Total protein amount in TA (mg) 9.2±0.42 18.9±0.38 <0.001  
Total glycogen content in TA (mg) 0.23±0.04 0.44±0.02 <0.01
Bw, body weight; QF, M. quadriceps femoris; BF, M. biceps femoris; Gastro, M. gastrocnemius; TA, M. tibialis anterior; EDL, M. exten-
sor digitorum longus. Values are mean ± SEM.
Figure 1. Representative panoramic images of Compact (A) and BALB/c (B) tibialis ante-
rior muscles stained by PAS. Average intensity of PAS-staining of the fibers on whole
muscle cross sectional area (C), average area of the fibers (D), average glycogen content
of the individual fibers (E) and total glycogen content of the tibialis anterior muscle (F)
based on PAS-staining (n=3-3). Data are reported as mean ± SEM; **P<0.01; ***P<0.001.
Scale bars: 200 µm.
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According to fiber size we found similar
results, i.e., the area of IIB fibers was the
greatest (IIA vs IIX, IIX vs IIB, IIA vs IIB in
BALB/c: superficial P<0.01, deep: P<0.05; IIX
vs IIB in Compact: superficial P<0.001; deep
P<0.01; Figure 4A), with no differences
between the superficial and deep regions of
the TA muscle in either mouse line, and no
changes were observed regarding the fiber
sizes of the two mice strains (Figure 4A).
To compare the effect of the Compact muta-
tion on the fiber-type specific glycogen content
of the muscle, we measured the average inten-
sity of PAS-staining of the different fiber types
on serial cryosections stained with antibodies
against the different types of MyHC isoforms
and PAS, respectively (Figure 2). The average
intensity of PAS-staining showed a similar
decreasing tendency in a rank order
IIA>IIX>IIB on the whole CSA of the muscle:
IIB fibers exhibited the weakest OD (Figure
3B), as in the superficial and deep regions
(Figure 4B) in both mouse lines. The average
intensity of PAS-staining of the different fiber
types did not show significant differences
between the Compact and BALB/c fibers on the
whole muscle CSA (Figure 3D), and no signif-
icant changes could be observed comparing
the PAS intensity of the fiber types in the
superficial and deep regions either (Figure
4B). However, the frequency distribution
revealed differences despite the similar aver-
age values of intensity of PAS-staining in
Compact and wild type mice: the Compact TA
muscle contained populations of IIX fibers with
higher, and IIB fibers with both higher and
lower intensity of PAS-staining resulting in a
wider distribution in mutant animals (Figure 3
E,F). Next, the average glycogen content of the
different fiber types was compared in both
strains. The average glycogen content of the
IIB fibers was greater than those of IIX fibers,
whereas the IIA was the lowest in the superfi-
cial and deep regions of wild type muscle
(Figure 4C). The results indicated significant
difference in the superficial region of BALB/c
animals (IIA vs IIX, IIX vs IIB, IIA vs IIB;
P<0.05; Figure 4C). The fiber type specific
glycogen content on the whole CSA revealed
similar tendency; however, without any signif-
icant changes (Figure 3G). In parallel with the
frequency distribution of PAS intensity (Figure
3 E,F), histograms of the average glycogen con-
tent (Figure 3 H,I) showed that the Compact
TA muscle contains a population of IIX fibers
with higher, and IIB fibers with both higher
and lower glycogen content . 
Finally, we compared the total glycogen con-
tent of the different fiber types in the TA mus-
cle. The glycogen index of IIB fibers was the
highest, so that the IIB fibers stored the most
glycogen in both BALB/c and Compact mice.
The glycogen index value of IIX fibers was 2.7-
fold larger (P<0.01) in BALB/c mice compared
to Compact animals (Figure 5) in line with the
higher number of IIX fibers present in BALB/c
mice. In contrast the glycogen index of IIB
fibers was 1.5-fold bigger in Compacts
(P<0.01) in good accordance with the
increased proportion of IIB fibers in Compact
mice.
Discussion
The Compact mutant mice carry a naturally
occurring 12-bp non-frame shift deletion in the
prodomain region of the precursor myostatin
resulting hypermuscularity.12 Additional modi-
fiers seem to be present to determine the full
expression of the phenotype; however, these
modifier genes have not been identified
yet.13,14
The condition of the double muscled pheno-
type has been observed in several species.
Natural mutations of myostatin can effect of
the bioactive domain of myostatin: the muta-
tion in Belgian Blue [nt821(del11)] causes a
frame-shift virtually eliminating all of the
mature, active regions of the molecule, where-
as Piedmontese cattle presents a G938A transi-
tion  resulting in a full-length, however mis-
folded and dysfunctional myostatin.4,21
Mutations in the pro-peptide leading an early
Original Paper
Table 2. Relative distribution of the different fiber types in BALB/c and Compact mice. 
Item BALB/c Compact P value
Total fiber number 3100±52.48 5200±227.6 <0.001
Fiber type frequency (%)
MyHCI 0 0
MyHCIIA 3±0.09 1±0.05 <0.001
MyHCIIX 47±2.59 19±3.25 <0.05
MyHCIIB 50±2.55 80±3.29 <0.01
MyHC, Myosin Heavy Chain. Values are mean ± SEM; n=3-3.
Figure 2. Representative microscopic images of the deep region of tibialis anterior mus-
cle of BALB/c and Compact mice. Serial sections were stained by either PAS or antibod-
ies against MyHCIIA and MyHCIIB isoforms. Representative fibers are marked as IIA,
IIB and IIX. Scale bar: 100 µm.
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STOP codon [nt419(del7-ins10), Q204X, and
E226X] have also been identified.22 The biolog-
ically active growth factor domain of myostatin
is unaffected by Compact mutation, therefore
the loss of myostatin activity cannot be
explained by disruption of the growth factor
bioactive domain; however, the Compactmuta-
tion can lead to misfolding, or defect in secre-
tion and mistargeting of mature myostatin.12
In the present study we depict, similarly to
previous observations,15,16,23,24 that the body and
muscle weights of Compact animals increased
compared to a mice line exhibiting wild type
myostatin gene. Thus, the disproportionate
increase of muscle weight can lead to
increased body weight of Compact mice.
Originally the Compact line was selected for
hypermuscularity and high protein content at
the Technical University in Berlin.11 Rehfeldt
and colleagues introgressed the Compact
mutation into the DUHi mice line.15 The hyper-
muscularity of this Compact-DUHi mice was
characterized by muscle fiber hyperplasia
rather than hypertrophy in fast glycolytic
longissimus dorsi and rectus femoris muscles,
and by balanced increases in myonuclear pro-
liferation and protein accretion.15 However, no
reports have so far examined the glycogen
amount of the Compact muscles and the glyco-
gen content of the individual fiber types. Here
we show that the total glycogen amount of the
TA muscle is markedly greater in Compact
than in wild type mice. The phenotype selec-
tion on extreme muscle mass in DU6P mice
revealed the co-evolution of high glycogen and
protein content of the muscle.25 This finding is
in line with our observation on the simultane-
ous increase of protein and glycogen contents
in Compact muscle. The PI3K/Akt signaling
plays a central role in integrating anabolic and
catabolic responses in skeletal muscle influ-
encing muscle mass.26,27 PTEN (Phosphatase
and tensin homolog) negatively affects the
Original Paper
Figure 3. Average area of fibers (A), average intensity of PAS-staining (D) and average
glycogen content of the different fiber types (G) on the whole cross sectional area of the
tibialis anterior muscle in the Compact and BALB/c mice (n=3-3). Histograms
(B,C,E,F,H,I) show the frequency distribution of the defined parameters. Data are
reported as mean ± SEM; **P<0.01; ***P<0.001.
Figure 4. Average area of fibers (A), average
intensity of PAS-staining (B) and average
glycogen content of the fiber types (C) in the
superficial and deep regions of the tibialis
anterior muscle in Compact and BALB/c
mice (n=3-3). Data are reported as mean ±
SEM; *P<0.05; **P<0.01; ***P<0.001. 
Figure 5. Glycogen index of the different
(IIA, IIX and IIB) fiber types of the tibialis
anterior muscle in BALB/c and Compact
mice. Data are reported as mean ± SEM
(n=3-3,  **P<0.01; ***P<0.001). 
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PI3K/Akt pathway;28 moreover, Sawitzky and
colleagues25 identified PTEN as a gate keeper
molecule in the co-evolutionary regulation of
high glycogen and protein content.
In order to analyze the glycogen content of
the individual muscle fibers the intensity of
PAS-staining was measured. However, the
value of the average OD of the pixels within a
fiber cannot reflect the glycogen content of the
whole muscle fiber; the OD value should be
multiplied by the fiber size. In accordance with
the literature15 we did not find differences
comparing the fiber sizes of the Compact and
wild type TA muscles. Furthermore, based on
our results, the average glycogen content of
the muscle fibers remained unchanged in
Compacts compared to wild type mice; there-
fore, the increased number of fibers can
explain the higher total glycogen amount of
the Compact TA muscle. In addition to control-
ling muscle mass, myostatin also appears to
regulate muscle fiber type composition postna-
tally by regulating the expression of both MyoD
and MEF2C genes.29 Histological analysis
revealed increased proportion of type IIB fibers
in tibialis anterior, biceps femoris29 and EDL
muscles23 of myostatin knockout mice, or in
double-muscled cattle.9,10 In accordance with
our observations, earlier studies described
that the Compact mutation induces a glycolyt-
ic shift in the phenotype of skeletal muscle;15,16
similarly to the situations evoked by the lack or
the dysfunction of myostatin. Rehfeldt and her
group reported that the number of white and
intermediate fibers increased in rectus femoris
and longissimus dorsi muscles of 70-day-old
Compact mice, whereas the density of the
blood capillaries decreased.15 Despite the fact
that the Compact mice are hypermuscular and
their muscles consist of significantly more
fibers, the specific force generation decreased
in Compact animals.23 According to our results,
the proportion of fast glycolytic fibers in TA
muscle of Compact mice increased; however,
their individual glycogen content did not. 
Regarding the size of the different fiber
types we found similar results in both Compact
and BALB/c mice: it increased in the rank
order IIA<IIX<IIB among the fast fibers. In
accordance with our observations, the area of
IIB fibers was the biggest in the rectus femoris
muscle of Compact-DUHi mice.15 The average
glycogen content of the individual muscle
fibers showed similar tendency as the fiber
size (i.e., increased in the rank order
IIA<IIX<IIB). Thus, the IIB fibers contained
the most glycogen in both Compact and BALB/c
mice, correlating with the biochemical proper-
ties of the fibers. Comparing the superficial
and deep regions of the TA muscle we found
similar results according to the fiber size,
intensity of PAS-staining, as well as the glyco-
gen content of the fibers. It is important to
note that the measurement of the PAS intensi-
ty alone cannot predict clearly the glycogen
content of the fibers (i.e., type IIB fibers have
lower average PAS intensity but higher fiber
size leading to larger glycogen content than
that of IIX fibers). Only a few data are available
on the glycogen content of the different types
of fast fibers, mainly reported in human mus-
cle biopsies. In accordance with our results,
type IIA fibers showed more intense PAS-stain-
ing than IIB fibers in human biopsy samples.30
In conclusion, the phenotype of the Compact
muscle is shifted towards glycolysis, similarly
to previous observations.15,16 Among the fibers
of the TA muscle, IIB fibers contained the most
glycogen, accompanied by their increased
number in Compact muscle. The myostatin
mutation was associated with elevated glyco-
gen content in the TA muscle without any
change in the glycogen content of individual
fibers despite the marked glycolytic shift. 
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